ACCENDRA HEALTH INC/VA/ (ACH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 3.5B 7B 10.5B Q3 '20: 8.3B Q4 '20: 8.5B Q1 '21: 8.7B Q2 '21: 9.4B Q3 '21: 9.7B Q4 '21: 9.8B Q1 '22: 9.9B Q2 '22: 9.9B Q3 '22: 9.9B Q4 '22: 10B Q1 '23: 10.1B Q2 '23: 10.1B Q3 '23: 10.2B Q4 '24: 4.7B Q1 '25: 2.7B Q2 '25: 2.7B Q3 '25: 2.7B Q4 '25: 2.8B Q1 '26: 2.7B Q2 '26: 2.6B Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 800M 1.6B 2.4B Q2 '20: 1.1B Q3 '20: 1.2B Q4 '20: 1.3B Q1 '21: 1.5B Q2 '21: 1.6B Q3 '21: 1.6B Q4 '21: 1.5B Q1 '22: 1.4B Q2 '22: 1.6B Q3 '22: 1.8B Q4 '22: 1.8B Q1 '23: 2B Q2 '23: 1.9B Q3 '23: 2B Q4 '23: 2.1B Q1 '24: 2.2B Q2 '24: 2.2B Q3 '24: 2.2B Q4 '24: 2.2B Q1 '25: 2.2B Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25

Operating Income TTM

-300M -150M 0 150M 300M 450M Q3 '20: 123M Q4 '20: 204.1M Q1 '21: 340.1M Q2 '21: 414.7M Q3 '21: 402.1M Q4 '21: 368.5M Q1 '22: 282.8M Q2 '22: 261M Q3 '22: 258.4M Q4 '23: 133.2M Q1 '24: 133.1M Q2 '24: 139.2M Q3 '24: 146.4M Q4 '24: -215M Q1 '25: -204.9M Q2 '25: -261.5M Q3 '25: -266.1M Q4 '25: 27.5M Q1 '26: 24.8M Q2 '26: 29.4M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '20: -59.9M Q4 '20: 29.9M Q1 '21: 110.8M Q2 '21: 232.3M Q3 '21: 230.4M Q4 '21: 221.6M Q1 '22: 191.3M Q2 '22: 154M Q3 '22: 122.4M Q4 '23: -41.3M Q1 '24: -38.8M Q2 '24: -42.4M Q3 '24: -48.8M Q4 '24: -362.7M Q1 '25: -365.8M Q2 '25: -1.2B Q3 '25: -1.3B Q4 '25: -1.1B Q1 '26: -1.1B Q2 '26: -302.1M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 3B 6B 9B Q3 '20: 7.1B Q4 '20: 7.2B Q1 '21: 7.2B Q2 '21: 7.8B Q3 '21: 8.1B Q4 '21: 8.3B Q1 '22: 8.4B Q2 '22: 8.3B Q3 '22: 8.1B Q4 '22: 8.1B Q1 '23: 8.1B Q2 '23: 8.2B Q3 '23: 8.3B Q4 '24: 3.1B Q1 '25: 1.4B Q2 '25: 1.4B Q3 '25: 1.4B Q4 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.5B Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-300M 0 300M 600M 900M Q3 '21: 144.9M Q4 '21: 124.2M Q1 '22: 178.5M Q2 '22: 281.3M Q3 '22: 288.4M Q4 '22: 325M Q1 '23: 403.7M Q2 '23: 627M Q3 '23: 715.9M Q4 '23: 740.7M Q1 '24: 529.4M Q2 '24: 332.4M Q3 '24: 202.3M Q4 '24: 161.5M Q1 '25: 179.4M Q2 '25: 100.9M Q3 '25: -99M Q4 '25: -101.8M Q1 '26: -116.8M Q2 '26: -180.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-400M -200M 0 200M 400M 600M Q3 '21: 89.7M Q4 '21: 83.2M Q1 '22: 132.9M Q2 '22: 192.7M Q3 '22: 164.6M Q4 '22: 166.9M Q1 '23: 209.1M Q2 '23: 438.4M Q3 '23: 526.6M Q4 '23: 568.3M Q1 '24: 357.1M Q2 '24: 162.4M Q3 '24: 22.3M Q4 '24: -8.8M Q1 '25: 9.3M Q2 '25: -82.5M Q3 '25: -299.1M Q4 '25: -292.7M Q1 '26: -303.6M Q2 '26: -357.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 60.6M Q2 '20: 61.1M Q3 '20: 60.9M Q1 '21: 70.9M Q2 '21: 75.8M Q3 '21: 76M Q1 '22: 76M Q2 '22: 76.3M Q3 '22: 76.4M Q1 '23: 75.2M Q2 '23: 75.8M Q3 '23: 76.2M Q1 '24: 76.3M Q2 '24: 76.7M Q3 '24: 78.5M Q1 '25: 77.3M Q2 '25: 76.9M Q3 '25: 77.3M Q1 '26: 76.4M Q2 '26: 76.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q3 '20: -0.98 Q4 '20: 0.47 Q1 '21: 1.64 Q2 '21: 3.42 Q3 '21: 3.24 Q4 '21: 2.99 Q1 '22: 2.53 Q2 '22: 2.03 Q3 '22: 1.61 Q4 '23: -0.53 Q1 '24: -0.50 Q2 '24: -0.55 Q3 '24: -0.63 Q4 '24: -4.73 Q1 '25: -4.76 Q2 '25: -15.64 Q3 '25: -17.42 Q4 '25: -14.32 Q1 '26: -14.08 Q2 '26: -3.94 Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.